If you liked this article you might like

CVS Remains Unsure About the Future of Obamacare, CEO Says
Mylan's Shares Rise Despite FTC Investigation
Express Scripts, Cigna Opt Out of Paying for EpiPen Competitor Auvi-Q
EpiPen Competitor Auvi-Q Will Return in February, but It'll Cost Insurance Companies Big Bucks